Max Jonson
Fortune : 380 316 $ au 31/05/2026
Fortune : 380 316 $ au 31/05/2026
Max Jonson is currently Director at BioLamina AB, Bure Growth AB, and Skanditek AB. Mr. Jonson is Chief Financial Officer at Bure Equity AB and Bure Equity since 2013.
Former roles include Director at Celemiab Group AB (2014–2016), Dipylon Medical AB (2016–2017), Atle Investment Management AB, and Celemi International AB (2016–2018).
Mr. Jonson was Associate Director-Corporate Finance at SEB Group (Sweden) from 1996 to 2003.
Other former positions include Chief Financial Officer at Orasolv AB (2011–2012), Stockholm School of Economics Ifl (2012–2013), Sse Executive Education (2012–2013), and ACQ Bure AB. Mr. Jonson was Finance Manager at Dpnova AB (2011–2013) and held a Chief Financial Officer role at Yubico AB. Education includes an MBA from The University of Chicago and undergraduate studies at New York University.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
BURE EQUITY AB 0,02 % | 01/06/2026 | 12 760 ( 0,02 % ) | 380 316 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| BURE EQUITY AB | Directeur Financier/CFO | 01/10/2013 |
Skanditek AB | Directeur/Membre du Conseil | - |
BioLamina AB
BioLamina AB BiotechnologyHealth Technology Develops, manufactures, and markets cell culture reagents intended for culturing of primary cells | Directeur/Membre du Conseil | - |
Bure Growth AB
Bure Growth AB Financial ConglomeratesFinance Provides investment services | Directeur/Membre du Conseil | - |
Bure Equity (Private Equity)
Bure Equity (Private Equity) Investment ManagersFinance Bure Equity invests in middle market companies located in Sweden. The firm targets companies operating across a broad range of sectors and industries. It provides financing for buyout transactions. | Directeur Financier/CFO | 01/09/2013 |
| Sociétés | Poste | Fin |
|---|---|---|
Celemi International AB | Directeur/Membre du Conseil | 01/01/2018 |
Dipylon Medical AB
Dipylon Medical AB Pharmaceuticals: MajorHealth Technology Engages in the research and development of pharmaceutical products and manufactures medical instruments | Directeur/Membre du Conseil | 01/01/2017 |
Celemiab Group AB
Celemiab Group AB Miscellaneous Commercial ServicesCommercial Services Provides consultancy and training services | Directeur/Membre du Conseil | 01/01/2016 |
Sse Executive Education | Directeur Financier/CFO | 01/01/2013 |
| ░░░░░░░░░ ░░░░░░ ░░ ░░░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 18 |
|---|---|
Bure Equity AB
Bure Equity AB Financial ConglomeratesFinance Provides equity and investment services | Finance |
Orasolv AB
Orasolv AB Medical/Nursing ServicesHealth Services Engages in the provision of dental care and acquisition of companies in the dental industry | Health Services |
The University of Chicago
The University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
New York University
New York University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bure Equity (Private Equity)
Bure Equity (Private Equity) Investment ManagersFinance Bure Equity invests in middle market companies located in Sweden. The firm targets companies operating across a broad range of sectors and industries. It provides financing for buyout transactions. | Finance |
Celemiab Group AB
Celemiab Group AB Miscellaneous Commercial ServicesCommercial Services Provides consultancy and training services | Commercial Services |
Dpnova AB
Dpnova AB Medical/Nursing ServicesHealth Services Develops and manufactures dental implants | Health Services |
Dipylon Medical AB
Dipylon Medical AB Pharmaceuticals: MajorHealth Technology Engages in the research and development of pharmaceutical products and manufactures medical instruments | Health Technology |
BioLamina AB
BioLamina AB BiotechnologyHealth Technology Develops, manufactures, and markets cell culture reagents intended for culturing of primary cells | Health Technology |
Stockholm School of Economics Ifl
Stockholm School of Economics Ifl Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Atle Investment Management AB | |
Bure Growth AB
Bure Growth AB Financial ConglomeratesFinance Provides investment services | Finance |
Celemi International AB | |
SEB Group (Sweden) | |
ACQ Bure AB
ACQ Bure AB Financial ConglomeratesFinance Operates as a special purpose acquisition company | Finance |
Skanditek AB | |
Sse Executive Education | |
Yubico AB
Yubico AB Electronics DistributorsDistribution Services Wholesales computers and software | Distribution Services |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national